The drug targets the overgrowth of synovial cells and inflammatory components that drive tumor development and joint ...

A 19-year-old woman with a history of depression and anxiety symptoms was admitted to the hospital because of seizure, ...

Norgine, announced today the inclusion of IFINWIL® (eflornithine) on Australia's Pharmaceutical Benefits Scheme (PBS). This listing comes just 3 months after receiving registration by the Therapeutic ...

Real-world data support the effectiveness of combining platinum-based chemotherapy with PD-1 inhibitors for recurrent limited ...

The Pharmaceutical Benefits Advisory Committee (PBAC) recommended the listing of eflornithine for post-maintenance treatment to prevent relapse in patients with high-risk neuroblastoma (HRNB) who are ...

Against steep odds and well-established paradigms, these four companies have successfully been commercializing their products ...

As July draws to a close, it's time to take a look at what's in store in the health and wellness space over the upcoming weeks.August, the last month of summer, includes several ...